Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-01-17 @ 10:24 PM
Study NCT ID:
NCT03674567
Status:
COMPLETED
Last Update Posted:
2025-01-24
First Post:
2018-09-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
Sponsor:
RAPT Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-09-14
First Submit QC Date:
None
Study First Post Date:
2018-09-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-21
Last Update Post Date:
2025-01-24
Last Update Post Date Type:
ACTUAL